Neurologic clinical trial - UCB CIDP04 OLE

Status:

Open (Study open and enrolling)

ClinicalTrials.gov:

NCT04051944

CONDITION: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) - TRIAL: An Open-Label Extension Study to Investigate the Long-Term Safety, Tolerability, and Efficacy of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Drug

Rozanolixizumab

Phase

Phase 2

Condition

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)

Keywords

Rozanolixizumab | CIDP04 | UCB Biopharma SRL